Market closedNon-fractional

Anixa Biosciences/ANIX

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Anixa Biosciences

Anixa Biosciences, Inc. is a biotechnology company developing vaccines and therapies that are focused on critical unmet needs in oncology. Its segments include CAR-T Therapeutics, Cancer Vaccines, Anti-Viral Therapeutics and Other. Its vaccine programs include the development of a preventative vaccine against triple negative breast cancer (TNBC), the most lethal form of breast cancer, as well as other forms of breast cancer and the development of a preventative vaccine against ovarian cancer. Its therapeutics programs include the development of a chimeric endocrine receptor T cell therapy, a novel form of chimeric antigen receptor T cell (CAR-T) technology, initially focused on treating ovarian cancer, which is being developed by its subsidiary, Certainty Therapeutics, Inc. (Certainty). Certainty is developing immuno-therapy drugs against cancer. The Company’s vaccine portfolio consists of technology focused on the immunization against specific retired proteins.

Ticker

ANIX

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology & Drugs

Headquarters

San jose, United States

Employees

4

ANIX Metrics

BasicAdvanced
$78M
Market cap
-
P/E ratio
-$0.35
EPS
0.85
Beta
-
Dividend rate
$78M
0.85
$5.13
$2.40
2.3
15.192
-40.49%
-41.01%
-41.26%
369.126
3.136
3.15
12.82%

What the Analysts think about ANIX

Analyst Ratings

Majority rating from 1 analysts.
Buy

ANIX Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
0.00% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$0
NaN%
Net income
-$3.2M
23.08%
Profit margin
0.00%
NaN%

ANIX Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 11.11%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.07
-$0.08
-$0.09
-$0.10
-
Expected
-$0.12
-$0.09
-$0.09
-$0.09
-$0.11
Surprise
-39.13%
-11.11%
0.00%
11.11%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Anixa Biosciences stock?

Anixa Biosciences (ANIX) has a market cap of $78M as of July 06, 2024.

What is the P/E ratio for Anixa Biosciences stock?

The price to earnings (P/E) ratio for Anixa Biosciences (ANIX) stock is 0 as of July 06, 2024.

Does Anixa Biosciences stock pay dividends?

No, Anixa Biosciences (ANIX) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next Anixa Biosciences dividend payment date?

Anixa Biosciences (ANIX) stock does not pay dividends to its shareholders.

What is the beta indicator for Anixa Biosciences?

Anixa Biosciences (ANIX) has a beta rating of 0.85. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell Anixa Biosciences stock

Buy or sell Anixa Biosciences stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing